Supprelin La

— THERAPEUTIC CATEGORIES —
  • Pituitary disorders

Supprelin La Generic Name & Formulations

General Description

Histrelin acetate 50mg; SC implant.

Pharmacological Class

GnRH agonist.

How Supplied

Kit—1 (w. implant and insertion tool)

Manufacturer

Generic Availability

NO

Supprelin La Indications

Indications

Central precocious puberty.

Supprelin La Dosage and Administration

Adult

Not applicable.

Children

<2yrs: not recommended. ≥2yrs: Insert 1 implant SC in the inner aspect of the upper arm. Remove after 12 months; may replace. Consider discontinuing at appropriate time point for onset of puberty.

Supprelin La Contraindications

Contraindications

Pregnancy.

Supprelin La Boxed Warnings

Not Applicable

Supprelin La Warnings/Precautions

Warnings/Precautions

Use aseptic technique. Initial transient rise in gonadotropins and sex steroids may result in increased signs/symptoms of puberty. Monitor for pseudotumor cerebri or psychiatric symptoms. History of seizures/epilepsy, cerebrovascular disorders, CNS anomalies or tumors: risk of convulsions. Monitor LH, FSH, and estradiol or testosterone at 1 month post implantation, then every 6 months thereafter. Assess height and bone age every 6–12 months. Nursing mothers.

Supprelin La Pharmacokinetics

See Literature

Supprelin La Interactions

Interactions

May interfere with pituitary gonadotropic and gonadal function tests. Caution with concomitant drugs that are associated with convulsions (eg, bupropion, SSRIs).

Supprelin La Adverse Reactions

Adverse Reactions

Implant site reactions (eg, discomfort, bruising, pain, soreness, erythema, swelling).

Supprelin La Clinical Trials

See Literature

Supprelin La Note

Not Applicable

Supprelin La Patient Counseling

See Literature